$BSX News

Insights Into Boston Scientific (BSX) Q3: Wall Street Projections for Key Metrics

Boston Scientific (BSX) Stock May Be 44% Undervalued As Neuromodulation Growth Builds

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors

Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth

Boston Scientific: A Better Valuation, But The Turnaround Needs Proof

Boston Scientific (BSX) Rises Higher Than Market: Key Facts

Boston Scientific (BSX) Recalls 262,686 Catheters Over Life Threatening Tip Failure Risk

Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $51

Earnings Preview: What to Expect From Boston Scientific’s Report

Is Johnson & Johnson (JNJ) Facing New MedTech Risk After A Patent Lawsuit?

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston sues J&J subsidiary over alleged patent infringement for cardiology device

Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors

Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know

Boston Scientific names Joseph Fitzgerald as chief operating officer

Why Is Boston Scientific (BSX) Reorganizing Into Three Segments Under A New COO?

Barclays Initiates Coverage of Boston Scientific with Equal-Weight

Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

Barclays Initiates Coverage On Boston Scientific with Equal-Weight Rating, Announces Price Target of $48

Boston Scientific Appoints Joseph M. Fitzgerald As EVP And COO, Effective January 1, 2027